Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation.
about
Risk assessment and experimental design in the development of a prolonged release drug delivery system with paliperidone.Preliminary study of nanonized lamotrigine containing products for nasal powder formulation.Quality by design approach for development of suspension nasal spray products: a case study on budesonide nasal suspension.Single Layer Extended Release Two-in-One Guaifenesin Matrix Tablet: Formulation Method, Optimization, Release Kinetics Evaluation and Its Comparison with Mucinex® Using Box-Behnken Design.Optimization of the Critical Parameters of the Spherical Agglomeration Crystallization Method by the Application of the Quality by Design Approach.
P2860
Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Adaptation of the quality by d ...... ranasal nanosized formulation.
@en
type
label
Adaptation of the quality by d ...... ranasal nanosized formulation.
@en
prefLabel
Adaptation of the quality by d ...... ranasal nanosized formulation.
@en
P2093
P1476
Adaptation of the quality by d ...... ranasal nanosized formulation.
@en
P2093
Edina Pallagi
Ildikó Csóka
Piroska Szabó-Révész
Rita Ambrus
P304
P356
10.1016/J.IJPHARM.2015.06.018
P407
P577
2015-06-29T00:00:00Z